Claims
- 1. A method of specifically diagnosing the localization of diseased tissue selected from the group consisting of an infarction and a necrosis comprising:
- administering a compound selected from the group consisting of a porphyrin-complex and an expanded porphyrin-complex, said compound being specific for the localization;
- allowing said compound to specifically accumulate in the localization; and
- detecting said compound in the localization.
- 2. The method of claim 1 wherein the localization resides in at least one organ selected from the group consisting of heart, kidney, intestine, lung and brain.
- 3. The method of claim 1 wherein the porphyrin-complex compound comprises a labeled metal selected from the group consisting of a radioactive metal, a paramagnetic metal and a super paramagnetic metal.
- 4. The method of claim 1 wherein the porphyrin-complex is administered in the amount of 0.001-1.0 mmol/kg body weight.
- 5. The method of claim 1 wherein the porphyrin-complex is gadolinium mesoporphyrin or manganese tetraphenylporphyrin.
Parent Case Info
This application is a continuation of application Ser. No. 08/375,919 filed on Jan. 23, 1995, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5284647 |
Niedballa et al. |
Feb 1994 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
937194 |
Jun 1994 |
ZAX |
9206097 |
Apr 1992 |
WOX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
375919 |
Jan 1995 |
|